Jennifer Little, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 603 Medical Pkwy, Enterprise, OR 97828 Phone: 541-426-5460 Fax: 541-426-7901 |
Shannon Elizabeth Wiedeman, NP AND RN Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 207 Sw 1st St, Enterprise, OR 97828 Phone: 541-426-0801 Fax: 541-426-0802 |
Anna L Hiebert, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 603 Medical Pkwy, Enterprise, OR 97828 Phone: 509-855-2438 |
Ms. Katie L Weller, CFNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 603 Medical Pkwy, Enterprise, OR 97828 Phone: 541-426-7900 Fax: 541-426-7901 |
Theresa A Russell, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 406 Ne 1st St, Enterprise, OR 97828 Phone: 541-426-4502 Fax: 541-426-6403 |
Sarah Georgine Peterson, DNP,ARNP,FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 107 North River Street, Suite B, Enterprise, OR 97828 Phone: 541-263-1225 |
Jacqueline Marie Russell, PMHNP-BC Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 606 Medical Pkwy, Enterprise, OR 97828 Phone: 541-426-4524 Fax: 541-426-3035 |
Kathleen Siebe, PNP Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 603 Medical Parkway, Enterprise, OR 97828 Phone: 541-426-4502 Fax: 541-426-6403 |
News Archive
Cellectis, announced today that scientists from Cellectis therapeutics, the French National Center For Medical Research (CNRS) and Institut de la Vision (Paris) have used its proprietary meganucleases to successfully prevent infection of cultured cells by a Herpes Simplex virus (HSV-1).
Much of what we know about Oetzi - for example what he looked like or that he suffered from lactose intolerance - stems from a tiny bone sample which allowed the decoding of his genetic make-up.
Children with sickle cell disease, an inherited red blood-cell disorder, are living longer, dying less often from their disease and contracting fewer fatal infections than ever before, researchers at UT Southwestern Medical Center at Dallas report. Their study, which will appear in the June edition of the scientific journal Blood, is the first to evaluate survival rates of children receiving the most modern treatments for sickle cell disease. It's also one of the largest published sickle cell studies to date. Researchers followed more than 700 Dallas-area children with the disease over two decades.
In 2016, the National Institutes of Health implemented a policy which requires grant applicants to "consider sex as a biological variable" in vertebrate animal and human studies. A new study surveyed NIH study section members in 2016 and 2017 regarding their attitudes toward the policy and found that a majority of respondents thought that it was important to consider SABV in the experimental design and that considering SABV would improve the rigor and reproducibility of NIH-funded preclinical research.
› Verified 5 days ago